We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Visage Imaging Debuts AI Offerings at Chicago Show

By MedImaging International staff writers
Posted on 27 Nov 2017
Print article
Image: The Visage 7 is the first and only system to combine both AI research and AI-assisted diagnostic interpretation in the same Enterprise Imaging platform (Photo courtesy of Visage Imaging).
Image: The Visage 7 is the first and only system to combine both AI research and AI-assisted diagnostic interpretation in the same Enterprise Imaging platform (Photo courtesy of Visage Imaging).
Visage Imaging, Inc. (Richmond, VIC, Australia) debuted its artificial intelligence (AI) offerings at the Radiological Society of North America (RSNA) 2017 annual meeting as part of the inaugural RSNA Machine Learning Showcase (November 26-30, Chicago, Illinois).

Visage aims to utilize its R&D capability and market leading technology to deliver cutting-edge AI offerings to optimize Enterprise Imaging worldwide. At RSNA 2017, the company showcased Visage 7 and the technology, which makes it the first and only system to combine both AI research and AI-assisted diagnostic interpretation in the same Enterprise Imaging platform.

“Historically, imaging platforms for research and diagnostic purposes have been totally separate. Visage’s GPU-based architecture is ideal for AI and, combined with our open APIs, will enable us to unify research and diagnostic imaging in ways not available before,” said Malte Westerhoff, PhD, co-founder and global CTO of Visage Imaging. “This will enable AI breakthroughs to advance patient care by giving radiologists faster access to new tools that help increase productivity and improve clinical accuracy.”

The company will also show algorithms working on the ultrafast and highly scalable Visage 7 Enterprise Imaging Platform. Both internally developed algorithms as well as third party algorithms from academic institutions and other companies will be demonstrated.

“AI is evolving rapidly and has the potential to transform Enterprise Imaging in ways previously not imagined,” said Dr. Sam Hupert, CEO of Visage Imaging. “We are well placed to capitalize on this transformation as we look to leverage our three key assets, namely our R&D capability, our technology platform and our growing base of blue chip clients.”

The company’s first AI innovations for Visage 7 are works-in-progress and are scheduled to be released in the first half of 2018.

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Multi-Use Ultrasound Table
Clinton
New
Imaging Table
CFPM201
Racks
Transducer Storage Racks and Stabilizers

Print article
Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: A prototype of the developed device (Photo courtesy of KTU)

Ultrasound Device Non-Invasively Improves Blood Circulation in Lower Limbs

Impaired blood circulation in the lower limbs is a common health issue among the elderly and is a significant complication of diabetes, often referred to as diabetic foot. This condition arises due to... Read more

Nuclear Medicine

view channel
Image: The Pixclara PET imaging agent for glioma could provide patients with greater diagnostic clarity (Photo courtesy of Telix)

New Imaging Agent to Drive Step-Change for Brain Cancer Imaging

Gliomas are highly diffusely infiltrative tumors that impact the surrounding brain tissue. They represent the most prevalent type of central nervous system (CNS) neoplasm originating from glial cells,... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.